Skip to content
Use caution Drug recall · FDA · Published December 7, 2012

West-Ward Recalls Carisoprodol Tablets Due to Foreign Substance

West-Ward recalls Carisoprodol 350mg tablets due to black spots. Check lot numbers 69364A, 69365A, 69365B for details.

🇺🇸 FDA recall #D-150-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

What happened, in plain English

West-Ward Pharmaceutical Corp. is recalling Carisoprodol Tablets, USP, 350 mg because they contain uncharacteristic black spots, indicating the presence of a foreign substance. The recall affects specific lots distributed nationwide. The record does not specify what consumers should do with these tablets. Read more at govinfonow.com/recall/48456-west-ward-pharmaceutical-corp-recalls-carisoprodol-tablets-usp-350-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/48456-west-ward-pharmaceutical-corp-recalls-carisoprodol-tablets-usp-350-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-150-2013

Cite this page

“West-Ward Recalls Carisoprodol Tablets Due to Foreign Substance.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48456-west-ward-pharmaceutical-corp-recalls-carisoprodol-tablets-usp-350-mg. Based on FDA recall #D-150-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-150-2013%22&limit=1).

Why it’s dangerous

The presence of uncharacteristic black spots on the tablets suggests contamination by a foreign substance. While the record does not detail specific health outcomes, ingesting medication with foreign material poses an unknown risk to consumer safety.

Who’s affected

Individuals who have purchased Carisoprodol Tablets, USP, 350 mg from West-Ward Pharmaceutical Corp. between the manufacturing dates and expiration date of October 2015. Consumers with lot numbers 69364A, 69365A, or 69365B are specifically affected.

How to tell if you have this one

Look for Carisoprodol Tablets, USP, 350 mg manufactured by West-Ward Pharmaceutical Corp. Check the bottle for black spots on the tablets. Verify if your lot number is 69364A, 69365A, or 69365B and that the expiration date is 10/15.

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Inspect Your Medication

    Check your bottles of Carisoprodol Tablets, USP, 350 mg for uncharacteristic black spots on the tablets.

  2. Verify Lot Numbers

    Confirm if your product has lot numbers 69364A, 69365A, or 69365B with an expiration date of 10/15.

  3. Contact Manufacturer

    Since the remedy is not stated in the record, contact West-Ward Pharmaceutical Corp. for further instructions on how to handle these tablets.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Dec 7, 201212. FDA classified it Class II: Feb 5, 201323. Published in FDA’s Enforcement Report: Feb 13, 201334. FDA terminated the recall: Dec 18, 2014420122014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where were these tablets sold?

The distribution pattern was nationwide.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-150-2013 (December 7, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-150-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA